Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DSGN - Design Therapeutics names new medical chief

DSGN - Design Therapeutics names new medical chief

Design Therapeutics Inc.
Design Therapeutics (NASDAQ:DSGN) announced the appointment of Jae Kim, M.D., as the company’s new Chief Medical Officer. Before joining Design (DSGN), Dr. Kim served as the chief medical officer at Avidity Biosciences, leading the advancement of its pipeline, including the start of a first-in-human Phase 1/2 clinical trial for myotonic dystrophy type-1. Prior to that Dr. Kim was Clinical Research Head, Vice President of Clinical Development, and Chair of the Clinical Trial Review Board at Alnylam Pharmaceuticals (NASDAQ:ALNY). “I am thrilled to welcome Jae to Design, particularly as we prepare to embark on the important transition to a clinical-stage company and initiation of our Phase 1 clinical trial in patients with Friedreich ataxia,” remarked Design’s (DSGN) CEO João Siffert. Read more on the Design Therapeutics’s (DSGN) strong market debut last year.

For further details see:

Design Therapeutics names new medical chief
Stock Information
Company Name: Design Therapeutics Inc.
Stock Symbol: DSGN
Market: NASDAQ
Website: designtx.com
Menu
DSGN DSGN Quote DSGN Short DSGN News DSGN Articles DSGN Message Board
Get DSGN Alerts

News, Short Squeeze, Breakout and More Instantly...